Ahfs Drug Information, 2000
Pharmacists and other healthcare professionals have relied on the American Society of Health-System Pharmacists RM for over a half century. Not just for professional support, but for the clinical and business information they need most.ASHP is still the organization that thousands depend on for reliable information: our library contains publications and electronic products covering everything from drug information to outcomes measurement.Today we're still innovating and capturing some of the best thinking in the business.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
activity acute addition administration adults adverse effects agents alternative aminoglycoside amphotericin and/or anti-infective antihistamines appear appropriate approximately associated averaged aztreonam bacteria caused caused by susceptible Cautions cefixime cefoperazone cefotaxime cefotetan cefoxitin ceftazidime ceftizoxime ceftriaxone cefuroxime cephalexin cephalosporins clearance clinical clinicians combination commercially available complete concentrations considered containing creatinine currently daily decreased discontinued disease distributed dosage dose drug effects evidence fluconazole given greater half-life human hydrochloride imipenem impairment increased indicate individuals infections infections caused infusion inhibited initial itraconazole ketoconazole less limited loratadine manufacturer meningitis mg/kg months occurred oral organisms parenteral patients receiving peak pediatric penicillin plasma concentrations pneumoniae potential Preparations procedures prophylaxis reactions recommended reconstituted regimen renal function reported resistant respectively risk serum concentrations severe single skin sodium solution stable strains studies suggest sulfate susceptibility testing suspension tablets therapy tion toxicity tract treatment ug/mL usual vitro weeks